ACS Biotech is a verifiable French biotechnology company (founded 2013) developing high-impact regenerative medicine for cartilage repair (chitosan hydrogel). However, the project submission itself is of extremely low quality, containing demonstrably false claims (e.g., 'most people have used my product') and generic placeholders (e.g., 'audience: everyone'). While the underlying technology is innovative and socially useful, the submission's lack of credibility and the project's early pre-clinical stage (minimal user adoption compared to the claim) result in a low Proof of Usefulness score relative to established mature projects.
Ready to Compete for $100k in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $100k in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline